Search Medical Condition
Please enter condition
Please choose location

Keelung City, Taiwan Clinical Trials

A listing of Keelung City, Taiwan clinical trials actively recruiting patients volunteers.

RESULTS

Found (29) clinical trials

A Study of Orally Administered JNJ-56136379 to Evaluate Safety Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I) and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)

Part 1: This is a first-in-human (FIH), double-blind (neither the researchers nor the participants know what treatment the participant is receiving), randomized (study medication assigned to participants by chance), placebo-controlled (an inactive substance; a pretend treatment [with no drug in it] that is compared in a clinical trial with a ...

Phase

106.95 miles

Learn More »

A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer

Primary Objectives: - Phase 1b (dose escalation portion): To assess the safety profile and determine the Dose Limiting Toxicity (DLT) and to define the recommended volumes (doses) of PEP503. - Phase 2 (expansion portion): To evaluate the anti-tumor activity in terms of the rate of locoregional control at one year ...

Phase

Clinical Feature and Outcome of Angiographic Coronary Artery Disease in Chronic Kidney Disease Patients

All patients who underwent cardiac catheterization for assessment of CAD at Keelung Chang Gung Memorial Hospital between 1992 and 2004 with continuous serum creatinine values measured before admission were included in this analysis. Data were obtained from medical records of the database center of our institution. Demographic and clinical data ...

Phase N/A

Prednisolone Priming Study in Patients With Chronic Hepatitis B

This is a Phase IV, multi-center, double-blinded, placebo control randomized study to evaluate the therapeutic effect of telbivudine with or without prednisolone priming in patients with chronic hepatitis B. Patients are allocated to either group A or B randomly. Group A: Patients initially receive a 4-week course of oral prednisolone ...

Phase

23.79 miles

Learn More »

Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B

The Phase 1b/2a assessments of the dose-related safety, PK, and initial antiviral efficacy of ABI-H0731 in hepatitis B patients will be conducted at approximately 17 different sites to meet enrollment goals of 108 chronic hepatitis B patients.

Phase

914.4 miles

Learn More »

Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease in Asia Pacific

The protocol has been amended to implement the following changes: - Alignment of the protocol to the updated GOLD consensus report of 2017 and the COPD fact sheet. - Alignment of the study endpoints to the study objectives.

Phase N/A

94.3 miles

Learn More »